Endra Life Sciences Inc (NDRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Operating Expenses | 10,817 | 10,521 | 13,158 | 11,498 | 11,502 |
| Operating Income | -10,817 | -10,521 | -13,158 | -11,498 | -11,502 |
| Other Income | -691 | 460 | -22 | 267 | -224 |
| Pre-tax Income | -11,508 | -10,060 | -13,179 | -11,231 | -11,726 |
| Net Income Continuous | -11,508 | -10,060 | -13,179 | -11,231 | -11,726 |
| Net Income | $-11,508 | $-10,060 | $-13,179 | $-11,231 | $-11,726 |
| EPS Basic Total Ops | -56.94 | -2,766.85 | -7,972.03 | -9,702.80 | -22,027.97 |
| EPS Basic Continuous Ops | -56.97 | -2,794.51 | -7,969.69 | -9,596.80 | -21,362.16 |
| EPS Diluted Total Ops | -56.94 | -2,766.85 | -7,972.03 | -9,702.80 | -22,027.97 |
| EPS Diluted Continuous Ops | -56.97 | -2,794.51 | -7,969.69 | -9,596.80 | -21,362.16 |
| EPS Diluted Before Non-Recurring Items | -46.05 | -2,762.24 | -7,972.03 | -9,790.21 | -22,027.97 |
| EBITDA(a) | $-10,611 | $-10,245 | $-12,923 | $-11,274 | $-11,104 |